Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Immuneering Corp changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 37 | 50 | +13 |
| Shares | 12.5M | 13.6M | +1.11M (+8.9%) |
| Value | $200.1M | $88.1M | −$112.0M (−56.0%) |
New holders (14)
Institutions that held Immuneering Corp at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Manufacturers Life Insurance Company, The | 84,525 | $572.8K | 0.00% |
| D. E. Shaw & Co., Inc. | 70,127 | $454.0K | 0.00% |
| Renaissance Technologies LLC | 57,600 | $373.0K | 0.00% |
| Two Sigma Investments, LP | 51,360 | $332.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 29,160 | $189.0K | 0.00% |
| Jump Financial, LLC | 19,300 | $125.0K | 0.01% |
| Walleye Capital LLC | 14,625 | $95.0K | 0.00% |
| Trexquant Investment LP | 14,272 | $92.0K | 0.00% |
| Rhumbline Advisers | 13,819 | $89.0K | 0.00% |
| Two Sigma Advisers, LP | 13,300 | $86.0K | 0.00% |
| Barclays PLC | 7,228 | $47.0K | 0.00% |
| Amalgamated Bank | 1,219 | $8.00K | 0.00% |
| Amalgamated Financial Corp. | 1,219 | $8.00K | 0.00% |
| High Net Worth Advisory Group LLC | 800 | $5.00K | 0.00% |
Sold out (1)
Institutions that held Immuneering Corp at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Rock Springs Capital Management LP | 1,089,816 | $17.6M |